Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain

ClinicalTrials.gov ID: NCT00564486

Public ClinicalTrials.gov record NCT00564486. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Randomized, Double-Blind Placebo-Controlled, Multicenter, Parallel-Group, Repeated-Dose Study of the Analgesic Efficacy & Safety of IV Acetaminophen Versus Placebo for the Treatment of Postop Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study will look at the pain relieving ability and safety of using repeated doses of intravenous (into the vein \[IV\]) acetaminophen in the treatment of moderate postoperative pain after planned or elective abdominal laparoscopic surgery, such as a laparoscopic abdominal hysterectomy or laparoscopic cholecystectomy (removal of the gall bladder).

Study identification

NCT ID
NCT00564486
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mallinckrodt
Industry
Enrollment
244 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Aug 31, 2008
Completion
Aug 31, 2008
Last update posted
Oct 20, 2016

2007 – 2008

United States locations

U.S. sites
17
U.S. states
8
U.S. cities
14
Facility City State ZIP Site status
Helen Keller Hospital Sheffield Alabama 35660
Precision Trials Phoenix Arizona 85032
Methodist Hospital Arcadia California 91007
Glendale Adventist Medical Center Glendale California 91206
Physicians Clinical Research Corporation Laguna Hills California 92653
Huntington Memorial Hospital Pasadena California 91105
Visions Clinical Research Boynton Beach Florida 33414
Nature Coast Clinical Research Crystal River Florida 34429
G and G Research, Inc. Ft. Pierce Florida 34950
Advanced Surgery Associates at Mercy Hospital Miami Florida 33133
University of Miami School of Medicine Miami Florida 33136
William Beaumont Hospital (Royal Oak) Royal Oak Michigan 48073
William Beaumont Hospital (Troy) Royal Oak Michigan 48073
Cooper University Hospital Camden New Jersey 08103
Staten Island University Hospital Staten Island New York 10305
Memorial Herman/Memorial City Hospital Houston Texas 77024
Texas Woman's Hospital Houston Texas 77024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00564486, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2016 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00564486 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →